Prognostic Significance of C-Reactive Protein Polymorphism and KRAS/BRAF in Synchronous Liver Metastasis from Colorectal Cancer

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Huang, Chi Jung ^a,b,c   Teng, Hao Wei ^d,e   Chien, Chih Cheng ^a,b   Lin, Jen Kou ^d,e   Yang, Shung Haur ^d,e  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; B RAF KINASE; C REACTIVE PROTEIN; GUANOSINE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; PREDICTION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; SECONDARY; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 84878634489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065117     Document Type: Article

References (36)

1. Ding Q, Chang CJ, Xie X, Xia W, Yang JY, et al. (2011) APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 121: 4526-4536.
2. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, et al. (2007) The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol 13: 821-825.
3. Khatri VP, Petrelli NJ, Belghiti J, (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23: 8490-8499.
4. Adam R, (2007) Colorectal cancer with synchronous liver metastases. Br J Surg 94: 129-131.
5. Ariake K, Ohtsuka H, Motoi F, Douchi D, Oikawa M, et al. (2012) GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett 325: 99-107.
6. Teng HW, Huang YC, Lin JK, Chen WS, Lin TC, et al. (2012) BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol 106: 123-129.
7. Barderas R, Bartolome RA, Fernandez-Acenero MJ, Torres S, Casal JI, (2012) High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res 72: 2780-2790.
8. Fransen K, Klintenas M, Osterstrom A, Dimberg J, Monstein HJ, et al. (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25: 527-533.
9. Bouchahda M, Karaboue A, Saffroy R, Innominato P, Gorden L, et al. (2010) Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Cancer Chemother Pharmacol 66: 605-609.
10. Charpin C, Martin M, Balandraud N, Roudier J, Auger I, (2010) Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis. Arthritis Res Ther 12: R194.
11. Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, et al. (2008) Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum 51: 443-449.
12. Vermeire S, Van Assche G, Rutgeerts P, (2005) The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2: 580-586.
13. Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, et al. (2009) C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genomics 19: 113-120.
14. Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, et al. (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 20: 1739-1751.
15. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
16. Yang SH, Huang CJ, Chang SC, Lin JK, (2011) Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol 18: 1907-1915.
17. Chang KH, Chen CM, Chen YC, Hsiao YC, Huang CC, et al. (2013) Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population. PLoS One 8: e54448.
18. Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, et al. (2007) Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 14: 786-794.
19. Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, et al. (2009) Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 100: 38-42.
20. Tan EK, Ooi LL, (2010) Colorectal cancer liver metastases- understanding the differences in the management of synchronous and metachronous disease. Ann Acad Med Singapore 39: 719-715.
21. Fujita S, Akasu T, Moriya Y, (2000) Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 30: 7-11.
22. Pai JK, Mukamal KJ, Rexrode KM, Rimm EB, (2008) C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One 3: e1395.
23. Lawlor DA, Harbord RM, Timpson NJ, Lowe GD, Rumley A, et al. (2008) The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS One 3: e3011.
24. Chiu HM, Lin JT, Chen TH, Lee YC, Chiu YH, et al. (2008) Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol 103: 2317-2325.
25. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, et al. (2006) K-ras activation generates an inflammatory response in lung tumors. Oncogene 25: 2105-2112.
26. Granville CA, Memmott RM, Balogh A, Mariotti J, Kawabata S, et al. (2009) A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One 4: e5061.
27. Okumura T, Ericksen RE, Takaishi S, Wang SS, Dubeykovskiy Z, et al. (2010) K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res 70: 8435-8445.
28. Zlobec I, Bihl MP, Schwarb H, Terracciano L, Lugli A, (2010) Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Int J Cancer 127: 367-380.
29. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, et al. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418: 934.
30. Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, et al. (2006) BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 5: 2.
31. Hutchins G, Southward K, Handley K, Magill L, Beaumont C, et al. (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29: 1261-1270.
32. Ferrone C, Dranoff G, (2010) Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 28: 4045-4051.
33. Mekenkamp LJ, Koopman M, Teerenstra S, van Krieken JH, Mol L, et al. (2010) Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer 103: 159-164.
34. Nikoloudis N, Saliangas K, Economou A, Andreadis E, Siminou S, et al. (2004) Synchronous colorectal cancer. Tech Coloproctol 8Suppl 1: s177-179.
35. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
36. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.